291 related articles for article (PubMed ID: 20206194)
1. Multi-hormonal weight loss combinations in diet-induced obese rats: therapeutic potential of cholecystokinin?
Trevaskis JL; Turek VF; Griffin PS; Wittmer C; Parkes DG; Roth JD
Physiol Behav; 2010 May; 100(2):187-95. PubMed ID: 20206194
[TBL] [Abstract][Full Text] [Related]
2. Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.
Roth JD; Trevaskis JL; Wilson J; Lei C; Athanacio J; Mack C; Kesty NC; Coffey T; Weyer C; Parkes DG
Int J Obes (Lond); 2008 Aug; 32(8):1201-10. PubMed ID: 18560368
[TBL] [Abstract][Full Text] [Related]
3. Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats.
Trevaskis JL; Lei C; Koda JE; Weyer C; Parkes DG; Roth JD
Obesity (Silver Spring); 2010 Jan; 18(1):21-6. PubMed ID: 19543217
[TBL] [Abstract][Full Text] [Related]
4. Control of food intake and energy expenditure by amylin-therapeutic implications.
Lutz TA
Int J Obes (Lond); 2009 Apr; 33 Suppl 1():S24-7. PubMed ID: 19363503
[TBL] [Abstract][Full Text] [Related]
5. Effects of amylin and bupropion/naltrexone on food intake and body weight are interactive in rodent models.
Clapper JR; Athanacio J; Wittmer C; Griffin PS; D'Souza L; Parkes DG; Roth JD
Eur J Pharmacol; 2013 Jan; 698(1-3):292-8. PubMed ID: 23178527
[TBL] [Abstract][Full Text] [Related]
6. Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents.
Trevaskis JL; Sun C; Athanacio J; D'Souza L; Samant M; Tatarkiewicz K; Griffin PS; Wittmer C; Wang Y; Teng CH; Forood B; Parkes DG; Roth JD
Diabetes Obes Metab; 2015 Jan; 17(1):61-73. PubMed ID: 25204356
[TBL] [Abstract][Full Text] [Related]
7. Diet-derived nutrients modulate the effects of amylin on c-Fos expression in the area postrema and on food intake.
Michel S; Becskei C; Erguven E; Lutz TA; Riediger T
Neuroendocrinology; 2007; 86(2):124-35. PubMed ID: 17703089
[TBL] [Abstract][Full Text] [Related]
8. Influence of high-fat feeding, diet-induced obesity, and hyperamylinemia on the sensitivity to acute amylin.
Boyle CN; Rossier MM; Lutz TA
Physiol Behav; 2011 Jul; 104(1):20-8. PubMed ID: 21550355
[TBL] [Abstract][Full Text] [Related]
9. Differential feeding behavior and neuronal responses to CCK in obesity-prone and -resistant rats.
Swartz TD; Duca FA; Covasa M
Brain Res; 2010 Jan; 1308():79-86. PubMed ID: 19857467
[TBL] [Abstract][Full Text] [Related]
10. Lesion of the lateral parabrachial nucleus attenuates the anorectic effect of peripheral amylin and CCK.
Becskei C; Grabler V; Edwards GL; Riediger T; Lutz TA
Brain Res; 2007 Aug; 1162():76-84. PubMed ID: 17617389
[TBL] [Abstract][Full Text] [Related]
11. Effects of a novel Y5 antagonist in obese mice: combination with food restriction or sibutramine.
Mashiko S; Ishihara A; Iwaasa H; Moriya R; Kitazawa H; Mitobe Y; Ito J; Gomori A; Matsushita H; Takahashi T; MacNeil DJ; Van der Ploeg LH; Fukami T; Kanatani A
Obesity (Silver Spring); 2008 Jul; 16(7):1510-5. PubMed ID: 18421274
[TBL] [Abstract][Full Text] [Related]
12. Effects of amylin on feeding of goldfish: interactions with CCK.
Thavanathan R; Volkoff H
Regul Pept; 2006 Jan; 133(1-3):90-6. PubMed ID: 16239037
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of amylin/leptin synergy in rodent models.
Turek VF; Trevaskis JL; Levin BE; Dunn-Meynell AA; Irani B; Gu G; Wittmer C; Griffin PS; Vu C; Parkes DG; Roth JD
Endocrinology; 2010 Jan; 151(1):143-52. PubMed ID: 19875640
[TBL] [Abstract][Full Text] [Related]
14. Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms.
Trevaskis JL; Coffey T; Cole R; Lei C; Wittmer C; Walsh B; Weyer C; Koda J; Baron AD; Parkes DG; Roth JD
Endocrinology; 2008 Nov; 149(11):5679-87. PubMed ID: 18669592
[TBL] [Abstract][Full Text] [Related]
15. Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice.
Kusakabe T; Ebihara K; Sakai T; Miyamoto L; Aotani D; Yamamoto Y; Yamamoto-Kataoka S; Aizawa-Abe M; Fujikura J; Hosoda K; Nakao K
Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E924-31. PubMed ID: 22275759
[TBL] [Abstract][Full Text] [Related]
16. Amylin and GLP-1 target different populations of area postrema neurons that are both modulated by nutrient stimuli.
Züger D; Forster K; Lutz TA; Riediger T
Physiol Behav; 2013 Mar; 112-113():61-9. PubMed ID: 23438370
[TBL] [Abstract][Full Text] [Related]
17. Interactions of amylinergic and melanocortinergic systems in the control of food intake and body weight in rodents.
Roth JD; D'Souza L; Griffin PS; Athanacio J; Trevaskis JL; Nazarbaghi R; Jodka C; Athanacio J; Hoyt J; Forood B; Parkes DG
Diabetes Obes Metab; 2012 Jul; 14(7):608-15. PubMed ID: 22276636
[TBL] [Abstract][Full Text] [Related]
18. Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats.
Morton GJ; Thatcher BS; Reidelberger RD; Ogimoto K; Wolden-Hanson T; Baskin DG; Schwartz MW; Blevins JE
Am J Physiol Endocrinol Metab; 2012 Jan; 302(1):E134-44. PubMed ID: 22008455
[TBL] [Abstract][Full Text] [Related]
19. Effects of prior or concurrent food restriction on amylin-induced changes in body weight and body composition in high-fat-fed female rats.
Roth JD; Hughes H; Coffey T; Maier H; Trevaskis JL; Anderson CM
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1112-7. PubMed ID: 17698985
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity.
Roth JD; Coffey T; Jodka CM; Maier H; Athanacio JR; Mack CM; Weyer C; Parkes DG
Endocrinology; 2007 Dec; 148(12):6054-61. PubMed ID: 17761760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
